These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16822398)

  • 21. [Role of transesophageal echography in the study of embolism of cardiac origin].
    Arrigo F; Carerj S; Pizzimenti G
    Cardiologia; 1993 Dec; 38(12 Suppl 1):301-17. PubMed ID: 8020030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis.
    Udell JA; Steg PG; Scirica BM; Eagle KA; Ohman EM; Goto S; Alsheikh-Ali AA; Porath A; Corbalan R; Umez-Eronini AA; Hoffman EB; Wilson PW; Bhatt DL;
    Eur J Prev Cardiol; 2014 Dec; 21(12):1531-40. PubMed ID: 23918840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes from the REACH Registry for Australian general practice patients with or at high risk of atherothrombosis.
    Reid CM; Ademi Z; Nelson MR; Connor G; Chew DP; Shiel L; Smeath A; De Looze F; Steg PG; Bhatt DL; Liew D;
    Med J Aust; 2012 Feb; 196(3):193-7. PubMed ID: 22339526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pan-cardiovascular syndrome - venous thromboembolism and atherothrombotic vascular disease.
    Weiss N
    Vasa; 2010 Aug; 39(3):207-11. PubMed ID: 20845579
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.
    Goto S; Bhatt DL; Röther J; Alberts M; Hill MD; Ikeda Y; Uchiyama S; D'Agostino R; Ohman EM; Liau CS; Hirsch AT; Mas JL; Wilson PW; Corbalán R; Aichner F; Steg PG;
    Am Heart J; 2008 Nov; 156(5):855-63, 863.e2. PubMed ID: 19061698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study.
    Bikkina M; Levy D; Evans JC; Larson MG; Benjamin EJ; Wolf PA; Castelli WP
    JAMA; 1994 Jul; 272(1):33-6. PubMed ID: 8007076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrovascular risk factors and clinical classification of strokes.
    Pinto A; Tuttolomondo A; Di Raimondo D; Fernandez P; Licata G
    Semin Vasc Med; 2004 Aug; 4(3):287-303. PubMed ID: 15630637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherothrombosis: a major health burden.
    Leys D
    Cerebrovasc Dis; 2001; 11 Suppl 2():1-4. PubMed ID: 11316915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).
    Krempf M; Parhofer KG; Steg PG; Bhatt DL; Ohman EM; Röther J; Goto S; Pasquet B; Wilson PW;
    Am J Cardiol; 2010 Mar; 105(5):667-71. PubMed ID: 20185014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epidemiology of cerebrovascular disease in Spain].
    Brea A; Laclaustra M; Martorell E; Pedragosa A
    Clin Investig Arterioscler; 2013; 25(5):211-7. PubMed ID: 24238835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The altered homeostatic theory: A hypothesis proposed to be useful in understanding and preventing ischemic heart disease, hypertension, and diabetes--including reducing the risk of age and atherosclerosis.
    Hellstrom HR
    Med Hypotheses; 2007; 68(2):415-33. PubMed ID: 16828234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The year in atherothrombosis.
    Sanz J; Moreno PR; Fuster V
    J Am Coll Cardiol; 2009 Apr; 53(15):1326-37. PubMed ID: 19358949
    [No Abstract]   [Full Text] [Related]  

  • 33. Inflammation, C-reactive protein, and atherothrombosis.
    Ridker PM; Silvertown JD
    J Periodontol; 2008 Aug; 79(8 Suppl):1544-51. PubMed ID: 18673009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrovascular risk factors, vascular disease, and neuropsychological outcomes in adults with major depression.
    Smith PJ; Blumenthal JA; Babyak MA; Hoffman BM; Doraiswamy PM; Waugh R; Hinderliter A; Sherwood A
    Psychosom Med; 2007; 69(6):578-86. PubMed ID: 17634564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The burden of peripheral artery disease and the role of antiplatelet therapy.
    Aronow H; Hiatt WR
    Postgrad Med; 2009 Jul; 121(4):123-35. PubMed ID: 19641278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
    Baumgartner I; Hirsch AT; Abola MT; Cacoub PP; Poldermans D; Steg PG; Creager MA; Bhatt DL;
    J Vasc Surg; 2008 Oct; 48(4):808-14. PubMed ID: 18639426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood pressure as a cardiovascular risk factor: prevention and treatment.
    Kannel WB
    JAMA; 1996 May 22-29; 275(20):1571-6. PubMed ID: 8622248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The REACH registry: baseline and 1-year results].
    Esmatjes E; Blanco AJ
    Med Clin (Barc); 2009 Sep; 132 Suppl 2():5-9. PubMed ID: 19631831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The economic implications of treating atherothrombotic disease in Australia, from the government perspective.
    Ademi Z; Liew D; Hollingsworth B; Wolfe R; Steg GP; Bhatt DL; Reid CM;
    Clin Ther; 2010 Jan; 32(1):119-32; discussion 106-7. PubMed ID: 20171418
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.